Sunandana Chandra, MD, MS

Advice for Patients Living with Metastatic Uveal Melanoma

September 02, 2022

Video

Sunandana Chandra, MD, MS, closes by sharing advice for patients with metastatic uveal melanoma.

Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy

September 02, 2022

Video

An overview of the treatment options for patients with mUM who ineligible for treatment with tebentafusp.

An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources

August 24, 2022

Video

Dr Sunandana Chandra highlights her personal experience in prescribing tebentafusp and other therapies for mUM, and discusses the educational resources and advocacy organizations that she encourages patients to look into to help make an informed decision about their treatment regimens.

Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM

August 24, 2022

Video

An oncologist outlines which patients with mUM are eligible for bispecific T-cell receptor immunotherapy, discusses logistical and safety considerations, and explains why pre-treatment HLA testing is required for those considering the regimen.